Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B982c968052d22dcd6f3588b8302114da> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B982c968052d22dcd6f3588b8302114da NCIT_P378 "NCI" @default.
- B982c968052d22dcd6f3588b8302114da type Axiom @default.
- B982c968052d22dcd6f3588b8302114da annotatedProperty IAO_0000115 @default.
- B982c968052d22dcd6f3588b8302114da annotatedSource NCIT_C172992 @default.
- B982c968052d22dcd6f3588b8302114da annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with afatinib in patients with solid tumors, excluding small cell and non-small cell lung carcinomas, or lymphomas that have activating EGFR gene mutations and progression following standard treatment." @default.